Zdrowie i gospodarka · 30/07/1998

FDA Classifies Cranial Orthosis into Class II with Special Controls

The FDA is requiring cranial orthosis manufacturers to obtain FDA approval before sale, with special controls including prescription use restrictions, biocompatibility testing, and labeling requirements, in response to a petition submitted under the Federal Food, Drug, and Cosmetic Act.